Key points from article :
British company HairClone is developing a cell therapy for male pattern baldness.
Treatment involves banking youthful hair follicles and cloning the dermal papilla cells to regrow hair.
Scientists believe it may be possible to predict a man's eventual hairline by analysing genetic markers inside dermal papilla cells.
HairClone is developing a test to establish whether the part of the scalp hair follicles come from is balding, destined to bald or will always retain its hair.
Around 200 clients have already banked hair, but treatment has not yet been tested in clinical trials.
HairClone is hoping to offer the treatment to patients on an experimental basis within the next 12-18 months.
